Lingli Huang Selected Research

Lingli Huang Research Topics

Disease

10	Infections 09/2022 - 05/2009
7	Neoplasms (Cancer) 05/2024 - 03/2017
6	Chronic Obstructive Pulmonary Disease (COPD) 03/2022 - 09/2013
4	Communicable Diseases (Infectious Diseases) 12/2022 - 01/2017
4	Body Weight (Weight, Body) 04/2020 - 12/2010
3	Salmonella Infections (Salmonellosis) 02/2024 - 01/2011
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023 - 01/2016
3	Bacterial Infections (Bacterial Infection) 08/2021 - 02/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2019
2	Breast Neoplasms (Breast Cancer) 06/2021 - 01/2019
2	Endometritis 01/2021 - 02/2020
2	Thinness 01/2021 - 03/2016
2	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2021
2	Inflammation (Inflammations) 12/2018 - 06/2012
2	Chromosome Aberrations (Chromosome Abnormalities) 11/2015 - 09/2013
2	Hypersensitivity (Allergy) 11/2013 - 01/2012
1	Colorectal Neoplasms (Colorectal Cancer) 05/2024
1	Ischemic Stroke 04/2024
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2023
1	Lymphatic Metastasis 11/2023
1	Neoplasm Metastasis (Metastasis) 11/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Ovarian Cysts (Ovarian Cyst) 04/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Coccidiosis 01/2021
1	Hemorrhage 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021

Drug/Important Bio-Agent (IBA)

5	aditoprimIBA 09/2022 - 12/2015
4	Adenosine Diphosphate (ADP)IBA 09/2022 - 11/2015
3	Proteins (Proteins, Gene)FDA Link 05/2024 - 12/2010
3	Sulfamethoxazole FDA LinkGeneric 12/2022 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 11/2015
3	EnrofloxacinIBA 08/2021 - 09/2013
3	MicroRNAs (MicroRNA)IBA 06/2021 - 03/2017
3	cyadoxIBA 02/2021 - 12/2018
3	tilmicosinIBA 10/2019 - 01/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2023 - 01/2019
2	cefquinomeIBA 01/2023 - 01/2015
2	danofloxacinIBA 03/2022 - 07/2021
2	ceftiofurIBA 11/2021 - 09/2020
2	SuspensionsIBA 11/2021 - 05/2016
2	Doxycycline (Periostat)FDA LinkGeneric 08/2021 - 05/2016
2	TylosinIBA 01/2021 - 01/2012
2	Phenformin (Fenformin)IBA 01/2021 - 01/2021
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021 - 03/2016
2	ChitosanIBA 11/2020 - 10/2019
2	polyethylene glycol polyethyleneimine nanogelIBA 11/2020 - 10/2019
2	MequindoxIBA 02/2017 - 11/2015
2	QuinoxalinesIBA 01/2016 - 11/2015
2	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 11/2015 - 09/2013
2	deoxynivalenolIBA 01/2014 - 06/2012
1	Biomarkers (Surrogate Marker)IBA 05/2024
1	Membrane Transport Proteins (Biological Pump)IBA 05/2024
1	ProteomeIBA 04/2024
1	FluoroquinolonesIBA 02/2024
1	Estrogen ReceptorsIBA 01/2024
1	Long Noncoding RNAIBA 11/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	Fluorouracil (Carac)FDA LinkGeneric 01/2023
1	folfirinoxIBA 01/2023
1	Leucovorin (Folinic Acid)FDA Link 01/2023
1	Interleukin-17 (Interleukin 17)IBA 05/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 05/2022
1	CytokinesIBA 05/2022
1	ChemokinesIBA 05/2022
1	Transcription Factors (Transcription Factor)IBA 05/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2022
1	NLR ProteinsIBA 05/2022
1	NF-kappa B (NF-kB)IBA 05/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	Isoleucine (L-Isoleucine)FDA Link 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	Peptidoglycan (Murein)IBA 01/2022
1	Valine (L-Valine)FDA Link 01/2022
1	Amino Acids FDA Link 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 01/2021
1	diaveridineIBA 01/2021
1	CL 331002 (glycylcycline)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Tigecycline (Tygacil)FDA Link 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2021
1	Tranexamic Acid (AMCA)FDA Link 01/2021
1	carboxymethyl-chitosanIBA 11/2020

Therapy/Procedure

5	Therapeutics 06/2021 - 05/2016
2	Immunotherapy 01/2022 - 06/2021
1	Drug Therapy (Chemotherapy) 01/2023
1	Intramuscular Injections 09/2022
1	Punctures 04/2021
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021